235 related articles for article (PubMed ID: 3274303)
1. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
[No Abstract] [Full Text] [Related]
2. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
Norin AJ
Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
[No Abstract] [Full Text] [Related]
3. Selective immunosuppression by drugs in balanced immune responses.
Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
[No Abstract] [Full Text] [Related]
4. Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice.
Malejczyk J; Osiecka A; Hyc A; Moskalewski S
Clin Orthop Relat Res; 1991 Aug; (269):266-73. PubMed ID: 1864049
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel saves rat heart allografts from rejection by inhibition of the primed anti-donor humoral and cellular immune response: implications for transplant patients with cancer.
Tange S; Scherer MN; Graeb C; Andrassy J; Justl M; Frank E; Jauch KW; Geissler EK
Transpl Int; 2003 Jul; 16(7):471-5. PubMed ID: 12677363
[TBL] [Abstract][Full Text] [Related]
6. Effect of niridazole in cellular immunity in vivo and in vitro.
Solbach W; Wagner H; Röllinghoff M
Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
[TBL] [Abstract][Full Text] [Related]
7. Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.
Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
Transplantation; 1986 Nov; 42(5):466-72. PubMed ID: 3538531
[TBL] [Abstract][Full Text] [Related]
8. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
Husberg BS
Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
[TBL] [Abstract][Full Text] [Related]
9. The role of cytotoxic T lymphocytes in corneal allograft rejection.
Hegde S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and organ transplantation.
Steinmuller DR
Cleve Clin Q; 1985; 52(2):263-70. PubMed ID: 3161666
[No Abstract] [Full Text] [Related]
11. Action of theophylline on humoral and cellular immune response mechanisms.
Gillissen G
Allergol Immunopathol (Madr); 1981; Suppl 9():218-22. PubMed ID: 7349730
[No Abstract] [Full Text] [Related]
12. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
Lowry RP; Gurley KE
Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
[TBL] [Abstract][Full Text] [Related]
13. In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection.
Ruiz P; Harland R; Yamaguchi Y; Bollinger RR; Sanfilippo F
Transplant Proc; 1989 Feb; 21(1 Pt 1):416-20. PubMed ID: 2650164
[No Abstract] [Full Text] [Related]
14. Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation.
Keown PA; Stiller CR; Ulan RA; Sinclair NR; Rankin C; Carruthers G; Wall WJ
Transplant Proc; 1981 Sep; 13(3):1669-72. PubMed ID: 6458135
[No Abstract] [Full Text] [Related]
15. Immunostimulation by Alsophila spinulosa extract fraction VII of both humoral and cellular immune responses.
Kao SF; Kuo HL; Lee YC; Chiang HC; Lin YS
Anticancer Res; 1994; 14(6B):2439-43. PubMed ID: 7872664
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
Winchurch RA; Hilberg C; Birmingham W; Munster AM
J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
[TBL] [Abstract][Full Text] [Related]
17. Alteration of cell-mediated immunity in the mouse following administration of 4-nitroquinoline 1-oxide.
Outzen HC; Prehn RT
Cancer Res; 1973 Feb; 33(2):408-10. PubMed ID: 4569790
[No Abstract] [Full Text] [Related]
18. Immunomodulating effects of anticancer drugs: the example of adriamycin.
Mihich E; Ehrke MJ
Transplant Proc; 1984 Apr; 16(2):499-501. PubMed ID: 6609456
[No Abstract] [Full Text] [Related]
19. Failure of bleomycin to affect humoral or cell-mediated immunity in the mouse.
Dlugi AM; Robie KM; Mitchell MS
Cancer Res; 1974 Oct; 34(10):2504-7. PubMed ID: 4137660
[No Abstract] [Full Text] [Related]
20. Effect of ICRF 159 on immune responses.
Hellmann K
Proc R Soc Med; 1972 Mar; 65(3):264-5. PubMed ID: 4563302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
